CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Phase II Study of Docetaxel and Cisplatin as First-line Chemotherapy in Patients with Recurrent or Metastatic Gastric Cance

Kyung-Ha Kim, Ki-Ju Jeung, Hyun-Jung Kim, Sang-Byung Bae, Chan-Kyu Kim, Nam-Su Lee, Kyu-Taek Lee, Sung-Kyu Park, Jong-Ho Won, Dae-Sik Hong, Hee-Sook Park

Cancer Research and Treatment. 2007;39(2):49-53. Published online 2007 June 30 DOI: https://doi.org/10.4143/crt.2007.39.2.49

Phase II Study of Docetaxel and Cisplatin as First-line Chemotherapy in Patients with Recurrent or Metastatic Gastric Cance

Kyung-Ha Kim, Ki-Ju Jeung, Hyun-Jung Kim, Sang-Byung Bae, Chan-Kyu Kim, Nam-Su Lee, Kyu-Taek Lee, Sung-Kyu Park, Jong-Ho Won, Dae-Sik Hong, Hee-Sook Park

Cancer Research and Treatment. 2007;39(2):49

Link1

Link2

A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma

Daniel T.T. Chua, Jonathan S.T. Sham, Gordon K.H. Au

Oral Oncology. 2005;41(6):589-595

Link1 Link2

2300 A multicenter randomized phase II study of docetaxel vs. docetaxel plus cisplatin vs. docetaxel plus S-1 as second-line chemotherapy in metastatic gastric cancer patients who had progressed after cisplatin plus either S-1 or capecitabine

B. Kim, K.W. Lee, M.J. Kim, H.S. Han, Y.L. Park, S.R. Park

European Journal of Cancer. 2015;51:S432

Link1 Link2

A Prospective Multicenter Phase II Study of Cisplatin and Weekly Docetaxel as First-Line Treatment of Recurrent or Metastatic NAsopharyngeal Cancer (KCSG HN07-01)

J.H. Ji

Annals of Oncology. 2012;23:xi156

Link1 Link2

1031 POSTER Weekly chemotherapy with cisplatin and docetaxel for recurrent metastatic head and neck cancer: a phase II study

European Journal of Cancer Supplements. 2005;3(2):297

Link1 Link2

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine

Keun-Wook Lee, Bum Jun Kim, Mi-Jung Kim, Hye Sook Han, Jin Won Kim, Young Iee Park, Sook Ryun Park

Cancer Research and Treatment. 2017;49(3):706-716

Link1

Link2 Link3

6547 A phase II study of Docetaxel and Oxaliplatin combination as first-line chemotherapy in recurrent gastric cancer patients after Fluoropyrimidine and/or Cisplatin adjuvant treatment

H. Kang, S. Oh, J. Kim, S. Nam, B. Kim, E. Song, S. Cho, J. Baek, H. Jeung, Y. Hong

European Journal of Cancer Supplements. 2009;7(2):375

Link1 Link2

Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer

Imjai Chitapanarux, Anun Tonusin, Vimol Sukthomya, Chamita Charuchinda, Nantaka Pukanhapan, Vicharn Lorvidhaya

Gynecologic Oncology. 2003;89(3):402-407

Link1 Link2

RM-018 Precise selection of metastatic gastric cancer patients for first line, docetaxel based chemotherapy: a retrospective study

P. Khatri, P. Kumari

Annals of Oncology. 2016;27:ii90

Link1 Link2 Link3

Efficacy, safety and health-related quality of life with epirubicin, cisplatin plus 5-FU (ECF) and docetaxel, cisplatin plus 5-FU (DCF) regimens as first-line systemic chemotherapy in metastatic gastric cancer: Final results of a phase II study

T. Chaudhuri, K.G. Babu, K.C. Lakshmaiah, L. Dasappa, L.A. Jacob, M.C.S. Babu, A.H. Rudresha, K.N. Lokesh, L.K. Rajeev

Annals of Oncology. 2017;28:x62

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.